MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Digital Mobility Outcomes for Modelling Self-Perceived Gait Security in People with Parkinsonian Disorders

    F. Boschi, S. Sapienza, M. Giraitis, G. Zelimkhanov, F. Terranova, H. Gaßner, J. Goncalves, J. Klucken (Belvaux, Luxembourg)

  • Digital Prediagnostic Mobility and Autonomic Trajectories in a Large Parkinson Disease Network

    T. Jansen, A. Hare, R. Gilron (San Francisco, USA)

  • Digital Respiratory Biomarkers as Early Indicators of Dysphagia and Aspiration Risk in Parkinsons Disease A Systematic Review

    M. Kakde, S. Kakde, S. Kakade (Pune, India)

  • Digital Speech Biomarkers Reveal Speech Changes in Physiological Aging and Parkinson’s Disease

    L. Novakova, K. Novotny, D. Kovac, J. Mekyska, I. Rektorova (Brno, Czech Republic)

  • Digitizing PD Rating Scales Increases Reliability and Accessibility

    Z. Yekutieli, Y. Yahalom, P. Lewitt (Tel-Aviv, Israel)

  • Directional versus Omnidirectional GPi-DBS in Parkinson’s Disease

    A. Kishore, M. Girija, S. Joshua, A. Nair, A. Hynse (Kochi, India)

  • Disabling Holmes Tremor Following Pontine Hemorrhage Accompanied by a Unique Constellation of Movement Disorders

    P. Cataniag, J. Cruz, J. Ong, C. Diesta, J. Oropilla, R. Teleg, K. Amamanglon, M. Mendoza (Makati City, Philippines)

  • Disassembly of α-Synuclein Aggregates by the All-D-peptide PRI-101: Preclinical Efficacy in Vitro and in Vivo.

    M. Sevenich, M. Feja, J. Jarazo, S. Reithofer, K. Korostov, S. Schemmert, F. Charbgoo, M. Wendt, G. Tamgüney, J. Schwamborn, F. Richter, D. Willbold, A. Willuweit (40225, Germany)

  • Discontinuation of Parkinson’s Disease Clinical Studies: A Cross-Sectional Analysis

    Y. Alnomani, A. Mady (Benha, Egypt)

  • Discontinuation Patterns and Predictive Factors in Continuous Subcutaneous Foslevodopa/Foscarbidopa (FLC/FCD) Therapy: Insights from Early Clinical Experience

    K. Waqar, M. Thomas, Y. Abdelmajid, E. Freitas, R. Cabrito, RH. Battah, A. Anjum, SH. Mittal (Abu Dhabi, United Arab Emirates)

  • « Previous Page
  • 1
  • …
  • 60
  • 61
  • 62
  • 63
  • 64
  • …
  • 208
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley